First-line treatments for patients with advanced ALK gene rearrangements in NSCLC: a systematic review and network meta-analysis

OBJECTIVE: To conduct a network meta-analysis of randomised controlled trials to determine the optimal clinical choice of first-line therapy for patients with ALK receptor tyrosine kinase (ALK) gene rearrangement non-small cell lung cancer (NSCLC). METHODS: Clinical trials in patients with histologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Jiahao, Zheng, Chuangjie, Zhang, Cuifen, Zhou, Ling, Liu, Zeyu, Zhou, Yanqun, Huang, Xuewu, Lin, Lizhu, Zhai, Linzhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Meta Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676299/
https://www.ncbi.nlm.nih.gov/pubmed/36380511
http://dx.doi.org/10.1177/03000605221132703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676299/
https://www.ncbi.nlm.nih.gov/pubmed/36380511
http://dx.doi.org/10.1177/03000605221132703

Ejemplares similares